SOUTH SAN FRANCISCO, CA, USA I 13, 2024 I TRex Bio, Inc. (“TRexBio”), a biotechnology company decoding human tissue immune biology to create ...
On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks ...
A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...
The California biotech has drawn partnerships with Eli Lilly and J&J on the promise of its approach to rebalancing the immune ...
From Oct. 11 through Nov. 6, shares of Eli Lilly fell 16.7%, largely in response to third-quarter results that missed Wall ...
The drug developed by U.S. pharmaceutical giant Eli Lilly and Co. will be offered to patients experiencing dementia and mild ...
ODBM is one of 91 organizations that received grants through a competitive round of Lilly Endowment’s Nurturing Children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback